Will Viking Therapeutics Be a Top Healthcare Stock in 10 Years?

Viking Therapeutics (NASDAQ: VKTX) is a healthcare company that possesses a lot of growth potential. And last year, its shares rose by 116%, as investors were bullish on its prospects.This year, however, has been a much different story, with the markets on shaky ground. Viking has lost more than 40% of its value since January.While there has been some significant volatility in the short term, there could still be a lot more room for Viking to be a much more valuable business in the long run, especially if it ends up having a top GLP-1 weight loss drug in its portfolio. Could Viking become one of the top healthcare stocks in the world in 10 years?Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool